Amar Kishan, MD
Amar Kishan, MD, Assistant Professor of Radiation Oncology and a member of the University of California, Los Angeles (UCLA) Jonsson Comprehensive Cancer Center, will receive the 2018 Publication Award from the Radiation Oncology Institute in recognition of a study highlighting the value of radiation therapy in the treatment of aggressive prostate cancer.1 The study was led by Dr. Kishan in collaboration with researchers at 11 institutions across the United States.
The report compared the clinical outcomes following three different types of treatment for an aggressive form of localized prostate cancer: radical prostatectomy, external-beam radiotherapy, and external-beam radiotherapy with a brachytherapy boost. Dr. Kishan and colleagues found that men with the disease who were treated with external-beam radiotherapy and a brachytherapy boost had a significantly improved overall long-term survival compared to the other two treatment options. ■
REFERENCE
1. Kishan AU, et al: Radical prostatectomy, EBRT, or EBRT with brachy-therapy boost and disease progression and mortality in patients with Gleason score 9-10 prostate cancer. JAMA 319:896-905, 2018.
